Salubris Biotherapeutics Inc
2 clinical trials · 2 recruiting · INDUSTRY
Trials by Salubris Biotherapeutics Inc
RECRUITINGPhase 2NCT07221513
Study of JK07 in Patients With Heart Failure and WHO Group 2 Combined Post- and Pre-Capillary Pulmonary Hypertension
This is a Phase 2a, open-label, multiple-dose study to assess the safety, tolerability, and efficacy of JK07 in participants 18 to 85 years of age with diagnosed HF and cpcPH. At...
Sponsor: Salubris Biotherapeutics IncEnrolling: 301 location
HFrEF - Heart Failure With Reduced Ejection FractionHFpEF - Heart Failure With Preserved Ejection FractionGroup 2 Pulmonary Hypertension
RECRUITINGPhase 2NCT06369298
Study of JK07 in Patients With Chronic Heart Failure
This is a Phase 2, randomized, double-blind, placebo-controlled, multiple dose study to assess the safety, tolerability, and efficacy of JK07 in participants aged 18-85 with heart...
Sponsor: Salubris Biotherapeutics IncEnrolling: 28220 locations
Heart Failure With Reduced Ejection FractionHeart Failure With Preserved Ejection Fraction